|
| Gene name | Relevance score | Related GO annotations | Related diseases |
|
| CDH1 | 183.35 | calcium ion binding and protein phosphatase binding | Gastric Cancer, Hereditary Diffuse and Blepharocheilodontic Syndrome 1 |
| CTNNB1 | 168.66 | DNA binding transcription factor activity and binding. | Mental Retardation, Autosomal Dominant 19 and Pilomatrixoma |
| CCND1 | 165.91 | protein kinase activity and enzyme binding | Myeloma, Multiple and Von Hippel-Lindau Syndrome |
| MMP9 | 139.39 | identical protein binding and metalloendopeptidase activity | Metaphyseal Anadysplasia 2 and Metaphyseal Anadysplasia |
| EPCAM | 114.16 | protein complex binding. | Diarrhea 5, with Tufting Enteropathy, Congenital and Colorectal Cancer, Hereditary Nonpolyposis, Type 8 |
| MMP2 | 92.35 | serine-type endopeptidase activity and metallopeptidase activity | Multicentric Osteolysis, Nodulosis, and Arthropathy and Arthropathy |
| PLAU | 89.58 | serine-type endopeptidase activity | Quebec platelet Disorder and Alzheimer Disease |
| MMP1 | 88.33 | calcium ion binding and metallopeptidase activity | Epidermolysis Bullosa Dystrophica, Autosomal Recessive and Recessive Dystrophic Epidermolysis Bullosa |
| IGF2 | 88.21 | growth factor activity and insulin receptor binding | Growth Restriction, Severe, with Distinctive Facies and Silver-Russell Syndrome |
| INS | 86.99 | identical protein binding and protease binding | Hyperproinsulinemia and Hiabetes Mellitus, Insulin-dependent, 2 |
|
